Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices | Market Insights | Japan | 2019

Japan’s aging population will drive steady growth in TEO procedure volumes through 2028, supporting TEO device market expansion, although revenue growth will continue to be hindered by the delayed entry of newer devices from international competitors and downward pricing pressure from biennial reimbursement cuts. Nonetheless, several new products will enter the market and see increasing adoption over the forecast period, supporting moderate market growth overall.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…